Topical steroid withdrawal syndrome: time to bridge the gap

Br J Dermatol. 2022 Nov;187(5):780-781. doi: 10.1111/bjd.21770. Epub 2022 Aug 20.

Authors

Chantal Cotter¹, Tim Burton², Andrew Proctor³, Celia Moss⁴, Carsten Flohr⁵

Affiliations

¹ St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
² Patient representative.
³ National Eczema Society, London, UK.
⁴ Department of Dermatology, Birmingham Children's Hospital, Birmingham, UK.
⁵ Unit for Paediatric & Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.

PMID: 35833942
DOI: 10.1111/bjd.21770

No abstract available

MeSH terms

Humans
Immunosuppressive Agents
Steroids
Substance Withdrawal Syndrome* / etiology

Substances

Steroids
Immunosuppressive Agents